MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1208/s12248-008-9043-6

Медицинская библиотека · The AAPS journal · 2008

Development, validation, and clinical implementation of an assay to measure total antibody response to naglazyme (galsulfase).

White Joleen T, Martell Lisa Argento, Van Tuyl Andrea, Boyer Ryan, Warness Laura, Taniguchi Gary T, Foehr Erik

СтатьяПеревод пока не подготовлен

Аннотация

Naglazyme (galsulfase, rhASB) was developed as enzyme replacement therapy for mucopolysaccharidosis type VI. Naglazyme generated an IgG antibody response in most patients. To better characterize Naglazyme immunogenicity, a solution phase bridged immunoassay was developed to measure total antibody response regardless of isotype. Overnight incubation of serum dilutions with rhASB labeled with biotin and ruthenium-based tags allowed antibody-antigen complexes to form prior to capture on a streptavidin plate. Neat serum was tolerated in the assay, with a 1:10 screening dilution implemented for testing. At this dilution, the assay was sensitive to 75 ng/ml anti-rhASB. Titers were reported as the highest dilution factor with signal above a 95% confidence interval from naïve individual sera. Precise measurement of titers, within two consecutive dilution factors, was observed across analysts and days. Clinical samples showed similar positive/negative results between the IgG ELISA and the total antibody ECLA, although with an imperfect correlation. Improvements in assay performance and implementation strategy altered some positive clinical samples to negative and vice versa. Comparison of the titer readout for clinical samples with the screening signal illustrates a range of relationships for signal versus sample dilution factor, confirming that signal from a screening dilution cannot directly predict the reported titer.

Для цитирования: White Joleen T, Martell Lisa Argento, Van Tuyl Andrea, Boyer Ryan, Warness Laura, Taniguchi Gary T, Foehr Erik. Development, validation, and clinical implementation of an assay to measure total antibody response to naglazyme (galsulfase).. The AAPS journal. 2008. DOI: 10.1208/s12248-008-9043-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.